Articles by Jerry Avorn, MD - Pharmaceutical Executive


Articles by Jerry Avorn, MD

Thought Leader: Better Business: Balancing Benefit, Risk, and Cost

Losing track of patient welfare and failing to address important safety problems isn't just bad science and bad ethics, it's also bad business.
Apr 1, 2005

Lower-priced drugs used by more patients may meet public health needs, as well as business needs, better than the often rapacious pricing we now see. This will become clearer with likely cutbacks in drug spending of Medicaid this year, and in the planned Medicare benefit next year.


Click here